Morning Briefing
Summaries of health policy coverage from major news organizations
Perspectives: Insurers Have Too Much Control Over Your Prescriptions; Should You Get The RSV Vaccine?
The law of demand applies to pharmaceuticals, but with one big difference. It鈥檚 not always the customer who decides that the price is too high. Often, it鈥檚 the insurer. (Keith Ericson and Tal Gross, 7/24)
The United States is approaching a public health milestone. With the recent recommendation by the Centers for Disease Control and Prevention to make anyone 60 and older eligible for the newly approved vaccine against the respiratory syncytial virus, this will be the first year that vulnerable individuals can protect themselves against the 鈥渢ripledemic鈥 of RSV, influenza and the coronavirus. (Leana S. Wen, 7/25)
This month, the FDA approved a birth control pill called Opill for over-the-counter pharmacy distribution. This is amazing news for reproductive autonomy. (Kim Adamski, 7/26)
